(EPC) Edgewell Personal Care - Ratings and Ratios
Razors, Sunscreen, Tampons, Wipes, Skincare
Dividends
| Dividend Yield | 3.45% |
| Yield on Cost 5y | 1.81% |
| Yield CAGR 5y | 41.42% |
| Payout Consistency | 60.9% |
| Payout Ratio | 27.8% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 39.2% |
| Value at Risk 5%th | 64.1% |
| Relative Tail Risk | -0.54% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.61 |
| Alpha | -61.16 |
| CAGR/Max DD | -0.34 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.421 |
| Beta | 0.651 |
| Beta Downside | 0.452 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.11% |
| Mean DD | 22.39% |
| Median DD | 18.28% |
Description: EPC Edgewell Personal Care November 15, 2025
Edgewell Personal Care Co. (NYSE:EPC) manufactures and markets a broad portfolio of personal-care products worldwide, organized into three operating segments: Wet Shave, Sun & Skin Care, and Feminine Care.
• The Wet Shave segment, anchored by Schick and Wilkinson Sword, sells razor handles, refillable and disposable blades, and shave-prep items (gels, creams) under brands such as Edge, Skintimate, Billie, and Shave Guard. It also produces private-label razors for retailers. • The Sun & Skin Care segment offers sun-protection, after-sun, and tanning products (Banana Boat, Hawaiian Tropic), antibacterial wipes (Wet Ones), men’s skin-care (Bulldog, Jack Black), and beard/hair care (Cremo). • The Feminine Care segment supplies tampons (Playtex Gentle Glide 360°, Playtex Sport, o.b.) and pads/liners (Stayfree, Carefree).
Edgewell distributes its brands through a mix of direct sales forces, exclusive and non-exclusive distributors, and wholesale partners, leveraging both brick-and-mortar and e-commerce channels. The company originated as Energizer Holdings and rebranded to Edgewell in June 2015; it traces its corporate lineage back to 1772 and is headquartered in Shelton, Connecticut.
Key recent metrics (FY 2023): total revenue of $3.4 billion, with the Wet Shave segment contributing roughly 45 % of sales and posting an operating margin of 12 %; Sun & Skin Care grew 4 % YoY, driven by premium sunscreen demand; and Feminine Care saw a modest 1.5 % decline amid shifting consumer preferences toward reusable products. Macro-level drivers include rising raw-material costs (e.g., steel for blades) and a continued consumer shift toward “clean” and sustainable personal-care formulations, which are reshaping product mix and pricing power.
For a data-rich, unbiased deep-dive into EPC’s valuation sensitivities and peer-group benchmarks, the ValueRay platform offers a structured framework that can help you test the robustness of any investment thesis.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (25.4m TTM) > 0 and > 6% of Revenue (6% = 133.4m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -3.58pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 19.34% (prev 16.52%; Δ 2.81pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 118.4m > Net Income 25.4m (YES >=105%, WARN >=100%) |
| Net Debt (1.19b) to EBITDA (185.6m) ratio: 6.40 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (46.5m) change vs 12m ago -7.19% (target <= -2.0% for YES) |
| Gross Margin 41.60% (prev 42.41%; Δ -0.81pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 59.39% (prev 60.41%; Δ -1.01pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.32 (EBITDA TTM 185.6m / Interest Expense TTM 73.2m) >= 6 (WARN >= 3) |
Altman Z'' 2.33
| (A) 0.11 = (Total Current Assets 995.5m - Total Current Liabilities 565.5m) / Total Assets 3.76b |
| (B) 0.29 = Retained Earnings (Balance) 1.09b / Total Assets 3.76b |
| (C) 0.03 = EBIT TTM 96.8m / Avg Total Assets 3.74b |
| (D) 0.44 = Book Value of Equity 977.6m / Total Liabilities 2.20b |
| Total Rating: 2.33 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 49.25
| 1. Piotroski 3.0pt |
| 2. FCF Yield 2.15% |
| 3. FCF Margin 1.86% |
| 4. Debt/Equity 0.91 |
| 5. Debt/Ebitda 6.40 |
| 6. ROIC - WACC (= -1.41)% |
| 7. RoE 1.66% |
| 8. Rev. Trend 17.84% |
| 9. EPS Trend 7.92% |
What is the price of EPC shares?
Over the past week, the price has changed by +4.00%, over one month by -7.19%, over three months by -19.16% and over the past year by -49.67%.
Is EPC a buy, sell or hold?
- Strong Buy: 4
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the EPC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 23.9 | 37.1% |
| Analysts Target Price | 23.9 | 37.1% |
| ValueRay Target Price | 15.2 | -12.5% |
EPC Fundamental Data Overview December 10, 2025
P/E Trailing = 30.0189
P/E Forward = 7.6161
P/S = 0.3325
P/B = 0.5005
P/EG = 2.39
Beta = 0.61
Revenue TTM = 2.22b USD
EBIT TTM = 96.8m USD
EBITDA TTM = 185.6m USD
Long Term Debt = 1.38b USD (from longTermDebt, last quarter)
Short Term Debt = 29.5m USD (from shortTermDebt, last quarter)
Debt = 1.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.19b USD (from netDebt column, last quarter)
Enterprise Value = 1.93b USD (739.2m + Debt 1.41b - CCE 225.7m)
Interest Coverage Ratio = 1.32 (Ebit TTM 96.8m / Interest Expense TTM 73.2m)
FCF Yield = 2.15% (FCF TTM 41.4m / Enterprise Value 1.93b)
FCF Margin = 1.86% (FCF TTM 41.4m / Revenue TTM 2.22b)
Net Margin = 1.14% (Net Income TTM 25.4m / Revenue TTM 2.22b)
Gross Margin = 41.60% ((Revenue TTM 2.22b - Cost of Revenue TTM 1.30b) / Revenue TTM)
Gross Margin QoQ = 38.83% (prev 42.81%)
Tobins Q-Ratio = 0.51 (Enterprise Value 1.93b / Total Assets 3.76b)
Interest Expense / Debt = 1.05% (Interest Expense 14.8m / Debt 1.41b)
Taxrate = 42.48% (-22.6m / -53.2m)
NOPAT = 55.7m (EBIT 96.8m * (1 - 42.48%))
Current Ratio = 1.76 (Total Current Assets 995.5m / Total Current Liabilities 565.5m)
Debt / Equity = 0.91 (Debt 1.41b / totalStockholderEquity, last quarter 1.55b)
Debt / EBITDA = 6.40 (Net Debt 1.19b / EBITDA 185.6m)
Debt / FCF = 28.67 (Net Debt 1.19b / FCF TTM 41.4m)
Total Stockholder Equity = 1.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.68% (Net Income 25.4m / Total Assets 3.76b)
RoE = 1.66% (Net Income TTM 25.4m / Total Stockholder Equity 1.53b)
RoCE = 3.32% (EBIT 96.8m / Capital Employed (Equity 1.53b + L.T.Debt 1.38b))
RoIC = 1.88% (NOPAT 55.7m / Invested Capital 2.97b)
WACC = 3.28% (E(739.2m)/V(2.15b) * Re(8.41%) + D(1.41b)/V(2.15b) * Rd(1.05%) * (1-Tc(0.42)))
Discount Rate = 8.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.04%
[DCF Debug] Terminal Value 74.86% ; FCFE base≈94.6m ; Y1≈83.3m ; Y5≈68.4m
Fair Price DCF = 24.99 (DCF Value 1.16b / Shares Outstanding 46.5m; 5y FCF grow -14.76% → 3.0% )
EPS Correlation: 7.92 | EPS CAGR: 13.71% | SUE: -0.84 | # QB: 0
Revenue Correlation: 17.84 | Revenue CAGR: 4.03% | SUE: 0.31 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.71 | Chg30d=-0.293 | Revisions Net=-7 | Analysts=8
EPS current Year (2026-09-30): EPS=2.37 | Chg30d=-0.340 | Revisions Net=-7 | Growth EPS=-6.0% | Growth Revenue=+1.7%
EPS next Year (2027-09-30): EPS=2.55 | Chg30d=-0.470 | Revisions Net=-4 | Growth EPS=+7.7% | Growth Revenue=+1.6%
Additional Sources for EPC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle